The Intestinal Microbiota in Inflammatory Bowel Disease (Q26795705)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

The Intestinal Microbiota in Inflammatory Bowel Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

23 February 2020

main subject

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

Markus F Neurath

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Christoph Becker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

192-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Effector and memory T cell responses to commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Saccharomyces boulardii does not prevent relapse of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Commensal-innate immune miscommunication in IBD pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A pathobiont of the microbiota balances host colonization and intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The microbial basis of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The human gut microbiome: current knowledge, challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A new vision of immunity: homeostasis of the superorganism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Lactase persistence, NOD2 status and Mycobacterium avium subsp. paratuberculosis infection associations to Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The genetics of Crohn's disease and ulcerative colitis--status quo and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The long-term stability of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The role of bacteria in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The treatment-naive microbiome in new-onset Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The gut microbiota in mouse models of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Epithelial barrier: an interface for the cross-communication between gut flora and immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Salmonella modulation of host cell gene expression promotes its intracellular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The role of infection in the aetiology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Inflammatory bowel disease as a model for translating the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Role of the gut microbiota in immunity and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The microbiome in inflammatory bowel disease: current status and the future ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Microbial learning lessons: SFB educate the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Gastrointestinal infection as a trigger for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Long-term temporal analysis of the human fecal microbiota revealed a stable core of dominant bacterial species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Clostridium difficileinfection and inflammatory bowel disease: Understanding the evolving relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Analysis of the c-kit gene in patients with slow transit constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Gut microbiota disturbance during antibiotic therapy: a multi-omic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Nod2 is required for the regulation of commensal microbiota in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Mycobacterium paratuberculosis DNA in Crohn's disease tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Growth and host interaction of mouse segmented filamentous bacteria in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Antibiotics and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Intestinal MicrobiOMICS to define health and disease in human and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Genetic variation in DLG5 is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The fundamental basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Human defensins in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Human gut microbiome viewed across age and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Epithelial NEMO links innate immunity to chronic intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Mouse models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Impact of Clostridium difficile on inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

VSL#3 for ulcerative colitis: growing evidence?

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Diarrheagenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?

1 reference

https://api.crossref.org/works/10.1093%2FILAR%2FILV030

7 January 2021

Identifiers

DOI

10.1093/ILAR/ILV030

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26323629%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017